EUCTR2013-000834-36-NL进行中(未招募)1 期
Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia. - Simvastatin in patients with recent-onset schizophrenia.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •A DSM-IV-R diagnosis of: 295.x (schizophrenia, schizophreniform disorder, or schizoaffective disorder) or 298.9 (psychosis NOS), no longer than 3 years ago.
- •Age between 18 and 50 years.
- •Written informed consent is obtained.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 250
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Presence of any of the contra-indications or warnings for the use of simvastatin as reported in the SPC
- •Chronic use of glucocorticosteroids (temporary use is permitted, if stopped at least 1 month before start of treatment trial)
- •Chronic use of non-steroidal anti-inflammatory drugs (temporary use is permitted, if stopped at least 1 month before start of treatment trial)
- •Current use of statins or other lipid-lowering drugs
- •Pregnancy or breast-feeding
- •Active liver, kidney or muscle disease as defined by alanine amino transferase (ALAT), creatinine or creatine kinase (CK) levels more than two times the upper boundary of normal levels
- •Use of comedication that either inhibits or induces the live enzyme CYP3A4 which is responsible for the degradation of simvastatin. Inhibitors of CYP3A4 include itraconazole, ketoconazole, posaconazole, fluconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, telaprevir, boceprevir, imatinib, ticagrelor, voriconazole; inducers of CYP3A4 include carbamazepine, efavirenz, nevirapin, etravirin (can be washed out before start of trial)
- •Use of comedication that may increase the risk for myalgia, rhabdomyolyse and myopathy, including colchicine, bosentan, fenobarbital, fenytoin, hypericum, rifabutin, rifampicin, fibrates (e.g. gemfibrozil), fusidic acid, carbamazepine (can be washed out before start of trial)
研究者
相似试验
已完成
3 期
Simvastatin addition to improve symptoms, cognition, metabolic syndrome and movement disorders in patients with recent-onset psychotic disorder.psychosis1000054610039628SchizophreniaNL-OMON47934niversitair Medisch Centrum Utrecht150
已完成
3 期
Simvastatine in the treatment of schizophreniaschizophrenia.schizophreniaIRCT201410021556N65Tehran University of Medical Sciences50
进行中(未招募)
不适用
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidEUCTR2011-004361-32-DEPhilipps-Universität Marburg
进行中(未招募)
2 期
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidA prospective multi-centre randomised double-blind placebo-controlled pilot studyL12.0Bullous pemphigoidDRKS00003851Philipps-Universität Marburg1
进行中(未招募)
1 期
RETRO-PRO: The effectiveness of simvastatin compared to atorvastatin: an e-clinical randomised trial within a research database in routine clinical practice - a feasibility study - RCTs within the database: a feasibility study of statin effectivenesssubjects who in the opinion of the GP investigator would require a statin for primary prevention according to the 2008 NICE guideline on lipid modification: adults over 40 who have a 20% or greater 10-risk of developing cardiovascular disease.EUCTR2009-014913-28-GBondon School of Hygiene & Tropical Medicine300
